Scynexis (SCYX) EBIT Margin Growth (3y) (2016 - 2026)
Scynexis (SCYX) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | -339,715.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -339,715.00 |
| Dec 31, 2025 | 153,156.00 |
| Sep 30, 2025 | -111,627.00 |
| Jun 30, 2025 | 94,213.00 |
| Mar 31, 2025 | -53,048.00 |
| Dec 31, 2024 | 291,058.00 |
| Sep 30, 2024 | 220,400.00 |
| Mar 31, 2024 | -67,927.00 |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 999,953.00 |
| Sep 30, 2021 | 607,924.00 |
| Mar 31, 2021 | 1.13 Mn |
| Jun 30, 2019 | -672,336.00 |
| Mar 31, 2019 | -726,406.00 |
| Dec 31, 2018 | -62,969.00 |
| Sep 30, 2018 | 192,969.00 |
| Jun 30, 2018 | -182,031.00 |
| Mar 31, 2018 | -217,541.00 |
| Dec 31, 2017 | -1.08 Mn |